Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
FMT appears safe and effective for IBD patients with recurrent C. difficile
Key clinical point: Fecal microbiota transplantation appears safe and effective for treating recurrent Clostridioides difficile infection in patients with inflammatory bowel disease.
Major finding: Thirty-four out of 37 patients were cured of Clostridioides difficile infection after one fecal microbiota transplantation (FMT).
Study details: A prospective trial involving 37 patients with inflammatory bowel disease and Clostridioides difficile infection.
Disclosures: Dr. Allegretti disclosed relationships with Merck, Openbiome, Finch Therapeutics, and others.
Citation:
Allegretti J et al. GMFH 2020.